Skip to main content
HR 4883 118th Congress House Health Congressional oversight Government information and archives Medicare Prescription drugs

Medicare Common Ownership Transparency Act of 2023

Introduced: July 25, 2023 Introduced by: Murphy, Gregory F. Republican · North Carolina See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Jul 28, 2023
Referred to the Subcommittee on Health.
Jul 25, 2023
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 25, 2023
Introduced in House
 Plain-English summary Congressional Research Service

Medicare Common Ownership Transparency Act of 2023

This bill requires Medicare Advantage (MA) organizations and prescription drug plan (PDP) sponsors under the Medicare prescription drug benefit to report certain information about affiliated health care providers. 

Specifically, MA organizations must report to the Centers for Medicare & Medicaid Services health care providers that the organization owns or in which the organization has a controlling interest, as well as the amount of incentive payments made to those health care providers and to other types of providers. PDP sponsors must similarly report pharmacies that the sponsor or a pharmacy benefit manager (PBM) owns or in which the sponsor or PBM has a controlling interest. 

The Medicare Payment Advisory Commission must report on the status of vertical integration between Medicare health care providers, pharmacies, PDP sponsors, MA organizations, and PBMs.

What's happening now December 17, 2024

Referred to the Subcommittee on Health.

 Committees of jurisdiction 4